Cardiovascular Risk Factors in Coronary Artery Bypass Graft Patients: Comparison Between Two Periods

Anas E Bifari1, Rakan K Sulaimani1, Yaser S Khojah1

  • 1Medicine, College of Medicine, King Abdulaziz University, Jeddah, SAU.

Cureus
|October 26, 2020
PubMed

Insights

Cardiovascular risk factors in Saudi Arabian coronary artery bypass graft patients showed a significant increase in smoking rates between 2012 and 2018. This highlights the need for targeted smoking cessation programs.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Limited data exists on cardiovascular risk factor trends in Saudi Arabian patients undergoing coronary artery bypass grafting (CABG).
  • Understanding these trends is crucial for public health initiatives and patient management.

Purpose of the Study:

  • To compare cardiovascular risk factors in patients who underwent first-time CABG in Saudi Arabia between 2012 and 2018.
  • To identify significant changes in risk factor prevalence over this period.

Main Methods:

  • A cross-sectional study analyzing hospital records from a tertiary center in Saudi Arabia.
  • Reviewed medical records of 72 patients from 2012 and 111 patients from 2018.
  • Statistical analysis included chi-square and independent t-tests, with P < 0.05 considered significant.

Main Results:

  • The prevalence of smoking significantly increased from 14.3% in 2012 to 27.0% in 2018 (P < 0.001).
  • While hypertension and diabetes mellitus showed slight increases, these were not statistically significant.
  • Hypercholesterolemia showed a non-significant decrease from 18.3% to 17.1%.

Conclusions:

  • A significant rise in smoking among CABG patients was observed, potentially linked to cultural factors and water-pipe smoking.
  • Increased awareness and smoking-cessation programs are recommended for this patient population.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
145
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
230
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
114
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
704